News
Pills no longer hard to swallow, with “natural drugs” in the making
Cancer and obesity among some of the health issues that Queensland researchers are trying to find a natural remedy for.
Potato chips and edible plants are among some of the “plant cures” under the microscope in efforts to treat cancer and obesity.
The unlikely “natural drugs” are part of world-first research conducted by 35 scientists from the university of Queensland.
Led by Professor David Craik, the team are working to find a cure for cancer and diabetes through somewhat unorthodox, yet gentle methods.
Additionally, the study is also looking at creating sustainable medications that are safer to consume.
“We’re engineering plants into super-efficient producers of next-generation medicines.”
Professor Craik told the ABC.
Professor Craik’s team is using the relationship between molecules and receptors in the brain to combat obesity-related illnesses.
As a result, appetite is reduced, with weight loss likely to occur.
“We have shown our molecules are very potent – a thousand millionth of a gram is enough to stimulate that receptor to effectively turn it off, so our appetite would be suppressed,” he said.
“So we want to put that molecule into, say, potatoes, so that effectively you can have your french fries and not worry about the consequences.”
Plants the key to pain relief
Professor Craik has also discovered that venom from plants and animals can be a key ingredient in pain-relief medications.
“The molecule from a Queensland cone snail is about 150 times more potent than morphine.
With alternate methods of medications being explored, Professor Craik and his team are also helping combat opioid addiction.
Natural treatments will mean patients who choose not to take medication because of their addiction, now have a substitute.
Researchers from the United States, United Kingdom, China, Sweden and Austria are also in on the project.
Clinical trials – which will see such cures tested on humans – are still five years away, but if successful could provide patients with cheaper and easier access to in-demand medications.
Written by Rebecca Borg
News
RBA holds rates as investors shift from property to stocks
RBA holds rates at 3.6%, shifting investor focus from property to potential stock market gains amid persistent inflation pressures.
RBA holds rates at 3.6%, shifting investor focus from property to potential stock market gains amid persistent inflation pressures.
The Reserve Bank of Australia has held interest rates at 3.6 percent, signalling a steady approach as inflation pressures persist and prompting investors to reassess their strategies in an uncertain climate.
The decision has shifted attention away from the property market, with experts suggesting the stock market may offer stronger opportunities, especially for those looking to outpace inflation over the long term.
We speak with Dale Gilham from Wealth Within about what the RBA’s call means for investors, why confidence in housing is changing, and what smarter financial choices look like in 2025.
Subscribe to never miss an episode of Ticker – https://www.youtube.com/@weareticker
#RBA #Interestrates #AustraliaEconomy #StockMarket #InvestingTips #WealthWithin #FinanceNews #TickerTV
News
U.S. retail sales slowdown sparks new fears ahead of Fed decision
U.S. retail sales weaken, raising concerns about consumer spending and economic resilience ahead of the holiday season.
U.S. retail sales weaken, raising concerns about consumer spending and economic resilience ahead of the holiday season.
Retail sales in the U.S. have unexpectedly weakened, raising new questions about consumer strength and the resilience of the economy. As Americans pull back on spending, analysts are watching closely to see whether this signals a broader shift toward caution in the lead-up to the holiday shopping period.
The slowdown has amplified uncertainty around the Federal Reserve’s next move on interest rates, as policymakers weigh mixed economic signals against cooling demand. With some categories falling sharply, economists warn that faltering retail activity could ripple into GDP forecasts and overall market confidence.
Brad Gastwirth from Circular Technologies joins us to break down which categories were hit hardest, why shoppers are becoming more value-conscious, and what this means for the economy heading into 2025.
Subscribe to never miss an episode of Ticker – https://www.youtube.com/@weareticker
#RetailSales #USEconomy #FederalReserve #ConsumerSpending #EconomicOutlook #MarketUpdate #InterestRates #TickerNews
News
xAI’s $15 billion raise, deadline pressure and Grokipedia launch
Elon Musk’s xAI plans $15 billion funding round, reaching $230 billion pre-money, amid fierce AI sector competition.
Elon Musk’s xAI plans $15 billion funding round, reaching $230 billion pre-money, amid fierce AI sector competition.
Elon Musk’s artificial intelligence startup xAI is preparing to close a huge $15 billion funding round next month, valuing the company at $230 billion pre-money. The raise highlights the intense investor appetite for advanced AI platforms as competition heats up across the sector.
Subscribe to never miss an episode of Ticker – https://www.youtube.com/@weareticker
#xai #elonmusk #ai #startupnews #grok #grokipedia #technews #fundinground
-
News2 days agoCanva overtakes Atlassian as Australia’s top tech giant
-
Tech4 days ago
Big Tech’s record debt fuels AI infrastructure concerns
-
Tech4 days ago
Amazon engineers heavily impacted by record layoffs
-
News4 days ago
EU stalls COP30 climate deal over fossil fuel concerns
-
Tech1 day ago
OpenAI launches shopping research tool for ChatGPT users
-
Shows3 days ago
Meet the fantastic four conquering Shanghai’s business landscape
-
News1 day ago
S&P 500 and Nasdaq rally on Alphabet’s AI boost
-
News2 days ago
Trump pushes Zelenskyy to accept controversial Ukraine peace deal
